The proteomic response in glioblastoma in young patients

Increasing age is an important prognostic variable in glioblastoma (GBM). We have defined the proteomic response in GBM samples from 7 young patients (mean age 36 years) compared to peritumoural-control samples from 10 young patients (mean age 32 years). 2-Dimensional-gel-electrophoresis, image anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Deighton, Ruth F., Le Bihan, Thierry, Martin, Sarah F., Barrios-Llerena, Martin E., Gerth, Alice M. J., Kerr, Lorraine E., McCulloch, James, Whittle, Ian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Laboratory Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129242/
https://www.ncbi.nlm.nih.gov/pubmed/24838487
http://dx.doi.org/10.1007/s11060-014-1474-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129242/
https://www.ncbi.nlm.nih.gov/pubmed/24838487
http://dx.doi.org/10.1007/s11060-014-1474-6

Ejemplares similares